Startups touting at-home coronavirus tests suspend plans after FDA warning
A handful of startups working on at-home #coronavirus test kits have suspended their efforts after new guidance from the FDA.
In a rapid about-face, a handful of startups that had already rolled out at-home coronavirus test kits or planned to start selling them soon have suspended their efforts. It’s the latest twist in an ongoing situation that has unfolded as tech companies have rushed to fill testing gaps with direct-to-consumer kits — and as regulators have rushed to wrangle them.
Late last week, several startups told that the new tests may not meet the Food and Drug Administration’s high standards for traditional approval, however, and cautioned that consumers might not get an accurate result if they didn’t swab deep enough in their nose or throat.
